ARTICLE | Clinical News
Azzalure abobotulinumtoxinA regulatory update
July 6, 2009 7:00 AM UTC
Ipsen and Galderma said Azzalure abobotulinumtoxinA was approved in Germany to treat moderate to severe glabellar lines (frown lines between the eyebrows) for aesthetic applications. Galderma plans to...